MEDITE Cancer Diagnostics, Inc., specializing in the development, manufacturing and marketing of superior molecular biomarkers and premium medical devices for detection, risk assessment and diagnosis of cancer and related diseases announced the recent decision of the German Patent Register to grant MEDITE the German priority patent for its Histology "Lab-in-one Automation" System.
from The Medical News http://ift.tt/1FnmaTu
from The Medical News http://ift.tt/1FnmaTu
No comments:
Post a Comment